首页> 外文期刊>Journal of Intellectual Disability Research >Carbamazepine in the treatment of epilepsy in people with intellectual disability
【24h】

Carbamazepine in the treatment of epilepsy in people with intellectual disability

机译:卡马西平治疗智障者的癫痫

获取原文
获取原文并翻译 | 示例
       

摘要

Carbamazepine is a major antiepileptic drug which is primarily used to treat epileptic patients suffering from partial seizures with or without secondary generalization, but which also has applications in those suffering from primary generalized tonic-clonic seizures. Besides its antiepileptic effect, carbamazepine is also indicated in the treatment of trigeminal and occipital neuralgia, and in manic depressive disorders. Because of its minimal unwanted effects on cognition and behaviour, carbamazepine is an excellent drug for the treatment of people with intellectual disability and epilepsy. Carbamazepine is still one of the most commonly prescribed medications in the treatment of epileptic disorders.
机译:卡马西平是一种主要的抗癫痫药,主要用于治疗伴有或不伴有继发性全身性发作的部分性癫痫发作的癫痫患者,但也可用于患有广泛性原发性强直-阵挛性癫痫发作的患者。卡马西平除具有抗癫痫作用外,还用于治疗三叉神经和枕部神经痛以及躁狂抑郁症。由于卡马西平对认知和行为的不良影响极小,因此它是治疗智障和癫痫患者的极佳药物。卡马西平仍然是治疗癫痫病最常用的药物之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号